0% found this document useful (0 votes)
11 views90 pages

Strept SF

2nd BHMS pathology practical

Uploaded by

Vasava Raghu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
11 views90 pages

Strept SF

2nd BHMS pathology practical

Uploaded by

Vasava Raghu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd

STREPTOCOCCUS

1
Strepto-cocci

2
 Commensals or Parasites of man & animals
 or
 Saprophytes of decaying matter

3
Genus Streptococcus

Gram-Positive Cocci in Pairs or Chains

v/s

Staph – gram positive cocci in clusters (grape like)

4
Gram-Positive
Streptococcus

5
 Gram positive cocci in clusters

6
Classification
 On the basis of their growth characteristics on
blood agar
 Alpha hemolytic
 Beta hemolytic
 Gamma hemolytic

7
Example –
Streptococcus viridans (Viridans = green)
Streptococcus pneumoniae
8
9
Example – enterococcus group

10
11
12
Beta hemolytic streptococci
Lancefield grouping
 Group A to Group V without I and J
 Divided according to differences in Cell wall
carbohydrate antigen
 Out of all these, those of Group A known as
streptococcus pyogenes produce majority
of human infections
 Group B are known as S agalactiae

13
Group A beta hemolytic streptococci /
strep pyogenes
 These are further subdivided according to sell
surface M, T and R antigens
 Griffith typing

14
15
Streptococcus Pyogenes
(Group A beta hemolytic)

16
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

17
Morphology
 Cocci in long chains

18
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

19
Growth characteristics
 Facultative anaerobe, grows best in presence
of 10% CO2
 Grows on enriched media only
 Beta hemolysis around colonies on blood
agar

20
21
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

22
Biochemical reactions
 Ferment sugars – produce acid , no gas
 Catalase negative
 Catalase helps to differentiate staphylococci
from streptococci

23
Catalase test

 Add hydrogen peroxide to culture material


24
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

25
Resistance
 Most are still susceptible to penicillin and
erythromycin

26
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

27
Pathogenicity and virulence
 Antigenic structure
 Antigens on surface of strep cross react with body proteins

Capsular hyaluronic acid – human joints – autoimmune arthritis

Carbohydrate antigen – cardiac valves – rheumatic heart
disease
 Toxins
 Enzymes
 Streptolysin O – ASO titre for diagnosis
 Streptolysin S – for hemolysis around colonies
 Streptokinase – lysis of clots – given iv for treatment of MI
 DNA ase – Anti DNAase is useful for diagnosis of S.
pyogenes skin infection
 Hyaluronidase – breaks down tissues – helps in spread of
strep infection

28
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

29
Epidemiology
 Source – human upper respiratory tract –
throat, pharynx, nose
 Transmission – direct contact, fomites

30
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

31
Diseases caused
 Pus producing (suppurative)
 Respiratory infections
 Skin and soft tissue infections
 Genital infections

 Non suppurative
 Acute rheumatic fever
 Rheumatic heart disease
 Acute glomerulonephritis (kidney)

32
Respiratory infections
 Tonsillitis
 Pharyngitis

33
 tonsillitis 34
 pharyngitis 35
Skin and soft tissue infections
 Skin
 Erysipelas – involves lymphatics – older pts
 Impetigo – young children
 Pyoderma

 Soft tissue
 Cellulitis
 Necrotising fascitis

36
Erysipelas

37
Impetigo

38
Pyoderma

39
Cellulitis

40
Necrotising fascitis
flesh eating bacteria (anaerobes)

41
Non suppurative complications

After 1-3 weeks of primary infection

Due to cross reactivity

42
Acute rheumatic fever
 Follows streptococcal sore throat

43
Acute glomerulonephritis
 Cross reaction between streptococci and
kidney tissues

44
Rheumatic heart disease

45
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

46
Suppurative infections
 Examination of pus/throat swabs
 Microscopy, staining and culture
 Gram stain
 Blood agar

47
Non suppurative infections
 Demonstration of antibodies
 Like ASO and anti DNA ase B

48
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

49
Treatment
 Penicillin
 Erythromycin
 Drugs have no effect if non suppurative
complications have developed

 Prophylaxis – can prevent rheumatic fever,


not glomerulonephritis

50
OTHER STREPTOCOCCI

BETA HEMOLYTIC - GROUP B


AND GROUP D

ALPHA HEMOLYTIC (VIRIDANS


GROUP)– STREPTOCOCCUS
PNEUMONIAE

51
Group B Streptococcus

Streptococcus agalactiae

52
Group B Streptococcus
S. agalactiae
1. Infect newborns
2. Infection acquired through maternal vagina during
birth
3. Presents as meningitis, pneumonia or septicemia

53
Diagnostic Laboratory Tests

 CAMP factor positive


 Hippurase positive

54
CAMP (Christie, atkins, munch-
peterson) Factor Test S. aureus
Group B
Streptococcus (Spingomyelinase C)

(CAMP Factor)
Group A
Streptococcus

Enhanced
Zone of
Hemolysis 55
Viridans group
Streptococcus pneumoniae

• Commonly referred to as pneumococcus

56
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

57
 Lancet shaped (one end broad, other
pointed)
 Capsulated
 Diplococci

58
S. pneumoniae: lancet-shaped diplococcus

59
S. pneumoniae
• Diplococcus

60
Capsular stain Indian Ink prep

61
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

62
Growth characteristics
 Alpha hemolysis on blood agar
 On further incubation, the colonies become
flat with raised edges and central elevation
resembling carrom coins / draughtsman

63
64
Example –
Streptococcus viridans (Viridans = green)
Streptococcus pneumoniae
65
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

66
Biochemical reactions
 Hiss serum water – fermentation of inulin
 Bile solubility

67
Inulin fermentation

68
69
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

70
Resistance
 Pneumococcus is sensitive to optochin –
used for typing
 Resistance to penicillin – third generation
cephalosporin like ceftriaxone
 May be resistant to third gen ceph also

71
72
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

73
Pathogenicity and virulence
 Capsule
 Toxins – pneumolysin
 C reactive protein

74
Capsule

75
Pneumolysin
 Membrane damaging toxin
 Cytotoxic activity

76
C reactive protein
 Abnormal immunoglobulin against C protein
of S. pneumoniae appears in serum of
patients
 Also seen in acute phase of infections and
inflammations
 CRP titre is tested in acute infections

77
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

78
Epidemiology

 Source – respiratory tract of humans


 Spread – droplets
 Carriers – pharynx
 Low immunity is responsible for fulminant
infections
 RSV infection, pulmonary congestion, stress,
malnutrition, alcoholism
 Splenectomy
 Sickle cell disease
79
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

80
Diseases caused
 Middle ear – otitis media
 Para nasal sinuses – sinusitis
 Respiratory tract – pneumonia, bronchitis,
empyema
 Meningitis is secondary to otitis media,
penumonia, sinusitis and conjunctivitis

81
Pneumococcal Pneumonia
Clinical Features
Abrupt onset
Fever
Shaking chill
Productive cough
Pleuritic chest pain
Dyspnea, tachypnea, hypoxia
11/24/24 Dr.T.V.Rao MD 82
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

83
Laboratory diagnosis
 Sample
 sputum – pneumonia
 septicemia - blood culture
 Otitis media - fluid from middle ear
 Meningitis - CSF

 Method
 Gram stain, microscopy
 culture

84
 Latex agglutination for pneumococcal antigen
in serum of patients

85
Description headings
 Morphology
 Growth characteristics
 Biochemical reactions
 Resistance
 Pathogenicity and virulence
 Epidemiology
 Diseases caused
 Laboratory diagnosis
 Treatment

86
Treatment
 Penicillin
 Amoxycillin
 ceftriaxone/ceftazidime
 Vancomycin

87
Prophylaxis
 Pneumococcal conjugate vaccine is available

 Given to splenectomy patients, sickle cell


anemia patients and susceptible individuals

88
GROUP D STREPTOCOCCI
Enterococcus faecalis
Enterococcus faecium

• GI tract of humans and animals


•Formerly Streptococcus

89
 Cause UTI, wound infection
 Endocarditis
 Intra abdominal abcesses

90

You might also like